<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-81614</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">The use of Xalacom® and deterioration in cases of vitiligo. Is there a causal relationship?</dc:title>
<dc:creator>Lara-Medina, J</dc:creator>
<dc:creator>Arnalich-Montiel, F</dc:creator>
<dc:creator>Muñoz-Negrete, F. J</dc:creator>
<dc:creator>Rebolleda, G</dc:creator>
<dc:language>es</dc:language>
<dc:source>Arch Soc Esp Oftalmol;79(7): 314-316, jul. 2004. ilus</dc:source>
<dc:identifier>ibc-81614</dc:identifier>
<dc:title xml:lang="es">Xalacom® y empeoramiento del vitíligo: ¿Relación causal?</dc:title>
<dc:subject>^d15222^s22036</dc:subject>
<dc:subject>^d15222^s22012</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d28053^s22057</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d11897^s22020</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:type>article</dc:type>
<dc:date>200407</dc:date>
</metadata>
</record>
</ibecs-document>
